NYSE: MCK | Healthcare / Medical Distribution / USA |
393.94 | +4.72 | +1.21% | Vol 227.04K | 1Y Perf 24.74% |
Jun 9th, 2023 11:28 DELAYED |
BID | 393.70 | ASK | 394.18 | ||
Open | 388.18 | Previous Close | 389.22 | ||
Pre-Market | - | After-Market | - | ||
- -% | - - |
Target Price | 420.82 | Analyst Rating | Strong Buy 1.35 | |
Potential % | 6.64 | Finscreener Ranking | ☆ 33.87 | |
Insiders Trans % 3/6/12 mo. | -100/-100/-100 | Value Ranking | ☆ 32.53 | |
Insiders Value % 3/6/12 mo. | -100/-100/-100 | Growth Ranking | + 31.86 | |
Insiders Shares Cnt. % 3/6/12 mo. | -100/-100/-100 | Income Ranking | + 26.20 | |
Price Range Ratio 52W % | 92.39 | Earnings Rating | Buy | |
Market Cap | 53.42B | Earnings Date | 2nd Aug 2023 | |
Alpha | 0.01 | Standard Deviation | 0.07 | |
Beta | 0.59 |
Today's Price Range 387.28395.70 | 52W Range 298.69401.78 | 5 Year PE Ratio Range -6.30782.60 |
Summary:
Neutral
Technical Indicators: | Neutral |
Moving Averages: | Buy |
Performance | |||
---|---|---|---|
1 Week | -0.24% | ||
1 Month | 0.13% | ||
3 Months | 15.85% | ||
6 Months | 4.80% | ||
1 Year | 24.74% | ||
3 Years | 141.47% | ||
5 Years | 167.74% | ||
10 Years | 246.16% |
Mngmt Effectiveness | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
ROE (5Y Avg) | -9.10 | |||
ROE last 12 Months | -182.61 | |||
ROA (5Y Avg) | -0.78 | |||
ROA last 12 Months | 3.51 | |||
ROC (5Y Avg) | 0.43 | |||
ROC last 12 Months | -40.46 | |||
Return on invested Capital Q | -50.28 | |||
Return on invested Capital Y | -36.45 | |||
Assets Turnover | 3.40 | |||
Receivables Turnover | 11.10 |
Valuation | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
27.40 | ||||
4.92 | ||||
0.27 | ||||
12.90 | ||||
16.10 | ||||
29.90 | ||||
-4.25 | ||||
-12.46 | ||||
59.04B | ||||
Forward PE | 13.00 | |||
PEG | 2.54 |
Financial Strength | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
0.50 | ||||
1.00 | ||||
0.56 | ||||
1.64 | ||||
18.30 | ||||
Leverage Ratio | -26.90 |
Profitability | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
4.70 | ||||
1.20 | ||||
1.50 | ||||
0.70 | ||||
1.08 |
Revenue | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
203.41B | ||||
1.43K | ||||
-5.27 | ||||
5.58 |
Dividends | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
0.57 | ||||
2.16 | ||||
5.62 | ||||
9.81 | ||||
Payout ratio | 12.00 |
Earnings History | Estimate | Reported | Surprise % |
---|---|---|---|
Q04 2023 | 7.16 | 7.19 | 0.42 |
Q03 2023 | 6.34 | 6.90 | 8.83 |
Q02 2023 | 6.13 | 6.06 | -1.14 |
Q01 2023 | 5.31 | 5.83 | 9.79 |
Q04 2022 | 6.06 | 5.83 | -3.80 |
Q03 2022 | 5.38 | 6.15 | 14.31 |
Q02 2022 | 4.67 | 6.15 | 31.69 |
Q01 2022 | 4.09 | 5.56 | 35.94 |
Earnings Per End | Estimate | Revision % | Trend |
---|---|---|---|
6/2023 QR | 5.85 | 0.17 | Positive |
9/2023 QR | 6.22 | -0.80 | Negative |
3/2024 FY | 26.56 | 0.91 | Positive |
3/2025 FY | 30.40 | 0.43 | Positive |
Next Report Date | 2nd Aug 2023 |
Estimated EPS Next Report | 5.85 |
Estimates Count | 7 |
EPS Growth Next 5 Years % | 10.80 |
Volume Overview | |
---|---|
Volume | 227.04K |
Shares Outstanding | 135.60K |
Shares Float | 135.42M |
Trades Count | 7.61K |
Dollar Volume | 89.05M |
Avg. Volume | 870.37K |
Avg. Weekly Volume | 721.00K |
Avg. Monthly Volume | 952.57K |
Avg. Quarterly Volume | 937.53K |
McKesson Corporation (NYSE: MCK) stock closed at 389.22 per share at the end of the most recent trading day (a 1.2% change compared to the prior day closing price) with a volume of 933.63K shares and market capitalization of 53.42B. Is a component of S&P 500, Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Medical Distribution industry, Healthcare sector and employs 76000 people. McKesson Corporation CEO is Brian S. Tyler.
The one-year performance of McKesson Corporation stock is 24.74%, while year-to-date (YTD) performance is 3.76%. MCK stock has a five-year performance of 167.74%. Its 52-week range is between 298.69 and 401.78, which gives MCK stock a 52-week price range ratio of 92.39%
McKesson Corporation currently has a PE ratio of 27.40, a price-to-book (PB) ratio of 4.92, a price-to-sale (PS) ratio of 0.27, a price to cashflow ratio of 12.90, a PEG ratio of 2.32, a ROA of 3.51%, a ROC of -40.46% and a ROE of -182.61%. The company’s profit margin is 1.08%, its EBITDA margin is 1.50%, and its revenue ttm is $203.41 Billion , which makes it $1 434.57 revenue per share.
Of the last four earnings reports from McKesson Corporation, there were 3 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $5.85 for the next earnings report. McKesson Corporation’s next earnings report date is 02nd Aug 2023.
The consensus rating of Wall Street analysts for McKesson Corporation is Strong Buy (1.35), with a target price of $420.82, which is +6.64% compared to the current price. The earnings rating for McKesson Corporation stock is Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
McKesson Corporation has a dividend yield of 0.57% with a dividend per share of $2.16 and a payout ratio of 12.00%.
McKesson Corporation has a Neutral technical analysis rating based on Technical Indicators (ADX : 7.74, ATR14 : 7.78, CCI20 : -72.10, Chaikin Money Flow : 0.12, MACD : 3.97, Money Flow Index : 35.23, ROC : -1.82, RSI : 53.76, STOCH (14,3) : 56.67, STOCH RSI : 0.37, UO : 59.58, Williams %R : -43.33), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of McKesson Corporation in the last 12-months were: Brian S. Tyler (Option Excercise at a value of $1 355 422), Brian S. Tyler (Sold 16 950 shares of value $5 738 814 ), Lori A. Schechter (Sold 15 000 shares of value $5 374 400 ), Nancy Avila (Sold 161 shares of value $59 573 ), Nancy Flores (Sold 161 shares of value $59 573 ), Napoleon B. Rutledge (Option Excercise at a value of $0), Rodgers Thomas (Sold 1 300 shares of value $477 373 ), Schechter Lori (Sold 10 000 shares of value $3 447 375 ), Thomas L. Rodgers (Sold 1 300 shares of value $477 373 ), Tracy L. Faber (Option Excercise at a value of $1 685 155), Tracy L. Faber (Sold 10 733 shares of value $4 202 844 ), Tyler Brian (Sold 9 534 shares of value $2 920 734 )
Analyst Ratings | Current | 1 M ago | 3 M ago |
---|---|---|---|
Strong Buy | |||
Moderate Buy | |||
Hold | |||
Moderate Sell | |||
Strong Sell | |||
Summary Rating | Strong Buy | Strong Buy | Strong Buy |
McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. Outside the U.S. market, McKesson engages in pharmaceutical wholesale and distribution in Europe and Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
CEO: Brian S. Tyler
Telephone: +1 972 446-4800
Address: 6555 State Highway 161, Irving 75039, TX, US
Number of employees: 76 000
Tue, 11 Apr 2023 10:20 GMT Analysts Offer Insights on Healthcare Companies: McKesson (MCK), NeoGenomics (NEO) and Allakos (ALLK)
- TipRanks. All rights reserved.Copyright © 2016-2023 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
All rights reserved. Financial Market Data powered by Quotemedia.com. All rights reserved. View the Terms of Use. NYSE/NYSE MKT (AMEX) data delayed 20 minutes. NASDAQ and other data delayed 15 minutes unless otherwise indicated. Copyright © 2023. All market data is provided by Quotemedia.com. Futures: at least a 10 minute delay. Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. To see all exchange delays and terms of use, please see disclaimer.
General partner of Finscreener is SLOVAKODATA, a.s.
Don´t have an account? Register
Looks like you are using AdBlock.
The revenue earned from advertising enables us to provide the quality content you are trying to reach on this website. In order to view this page, please disable AdBlock or purchase Premium.
Sign in if you already have Premium account.
This could take some time, please wait.